U.S. Ambulatory Surgical Centers Market Size By Ownership (Physician Only, Hospital Only, Corporation Only, Physician & Hospital, Physician & Corporation, Hospital & Corporation), By Surgery Type (Dental, Otolaryngology, Endoscopy, Obstetrics/Gynecology,

U.S. Ambulatory Surgical Centers Market Size By Ownership (Physician Only, Hospital Only, Corporation Only, Physician & Hospital, Physician & Corporation, Hospital & Corporation), By Surgery Type (Dental, Otolaryngology, Endoscopy, Obstetrics/Gynecology, Ophthalmology, Orthopedic, Cardiovascular, Neurology, Plastic Surgery, Podiatry), By Specialty Type (Single Specialty, Multi-specialty), By Service (Diagnosis, Treatment), Industry Analysis Report, Growth Potential, Covid-19 Impact Analysis, Competitive Market Share & Forecast, 2023 - 2032

U.S. ambulatory surgical centers (ASCs) market is expected to grow positively through 2032 owing to the availability of minimally invasive treatments. In addition, promising reimbursements as well as government policies are also expected to boost the industry growth.

The U.S. market for ambulatory surgical centers is anticipated to expand continuously as a result of the exponential rise in healthcare spending and surging demand for patient-centered healthcare practices. The market valuation will also be fueled by an aging population, favorable reimbursements, chronic diseases, and government initiatives. The benefits of minimally invasive procedures also influence patients' preference for ASCs.

Leading behemoths in U.S. ambulatory surgical centers market are relentlessly working toward new launches, innovations, and facility development. For instance, in January 2021, SurgCenter Development (SCD) announced the development of Advanced Surgical Care of Maryland. Both outpatient orthopedic surgery and pain management are likely to be offered at the new surgical location. Such trends are expected to propel the market outlook.

The U.S. ambulatory surgical centers industry has been categorized in terms of ownership, surgery type, specialty type, and service.

Based on ownership, the physician-only segment was valued at more than $21.5 billion in 2022. The strong segmental growth of physician-only ASCs can be ascribed to the high demand for affordable treatments. Meanwhile, the corporation-only segment is anticipated to amass sizeable revenue by the end of 2032. Significant investments have been made in the corporation-only ASCs segment as a result of the growing funding and raising awareness initiatives by public and private bodies to promote surgical treatments at ASCs, fostering the industry growth.

With respect to surgery type, the endoscopy segment held over 15% market share in 2022. The increasing number of aging populations that is particularly prone to various diseases is likely to boost market growth through the forecast period. Elderly patients frequently struggle with financial burden; hence ASCs are frequently favored by this patient population because they are more affordable than hospitals.

In terms of specialty, the single specialty segment is projected to garner steady growth over the research timeline fueled by the increase of ambulatory surgery centers with a single specialty. Additionally, cost-effectiveness, reduced chances of physical attrition, and a huge number of facilities with single specializations are likely to promote the industry growth during 2023-2032.

On the basis of service, the diagnosis segment is subjected to expand notably through the forthcoming years credited to the surging public awareness regarding early disease diagnosis. Besides, availability of advanced technologies for early disease detection and quality care at low cost offered at ASCs would further complement the industry progression.